Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2007 1
2008 2
2009 1
2011 1
2012 1
2013 1
2014 1
2015 2
2016 5
2017 6
2018 7
2019 6
2020 5
2021 6
2022 13
2023 12
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Clinical and cognitive characteristics of subjects with schizophrenia and childhood attention-deficit/hyperactivity disorder: Results from the multicentric FACE-SZ cross-sectional dataset.
Dondé C, Coulon N, Turbé H, Andre M, Boyer L, Capdevielle D, Chereau I, Dassing R, Dorey JM, Dubertret C, Leignier S, Llorca PM, Misdrahi D, Passerieux C, Pignon B, Rey R, Schorr B, Schürhoff F, Urbach M, Fond G, Mallet J. Dondé C, et al. Among authors: misdrahi d. Schizophr Res. 2024 Feb;264:105-112. doi: 10.1016/j.schres.2023.12.010. Epub 2023 Dec 20. Schizophr Res. 2024. PMID: 38128341
Poverty and inequality in real-world schizophrenia: a national study.
Fond GB, Yon DK, Tran B, Mallet J, Urbach M, Leignier S, Rey R, Misdrahi D, Llorca PM, Schürhoff F, Berna F, Boyer L. Fond GB, et al. Among authors: misdrahi d. Front Public Health. 2023 Oct 31;11:1182441. doi: 10.3389/fpubh.2023.1182441. eCollection 2023. Front Public Health. 2023. PMID: 38026279 Free PMC article.
Predictors of medication adherence in a large 1-year prospective cohort of individuals with schizophrenia: insights from the multicentric FACE-SZ dataset.
Misdrahi D, Dupuy M, Dansou Y, Boyer L, Berna F, Capdevielle D, Chereau I, Coulon N, D'Amato T, Dubertret C, Leignier S, Llorca PM, Lançon C, Mallet J, Passerieux C, Pignon B, Rey R, Schürhoff F, Swendsen J, Urbach M, Szöke A, Godin O, Fond G; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) Group. Misdrahi D, et al. Transl Psychiatry. 2023 Nov 7;13(1):341. doi: 10.1038/s41398-023-02640-x. Transl Psychiatry. 2023. PMID: 37935695 Free PMC article.
Adjunctive agents to antipsychotics in schizophrenia: a systematic umbrella review and recommendations for amino acids, hormonal therapies and anti-inflammatory drugs.
Fond G, Mallet J, Urbach M, Benros ME, Berk M, Billeci M, Boyer L, Correll CU, Fornaro M, Kulkarni J, Leboyer M, Llorca PM, Misdrahi D, Rey R, Schürhoff F, Solmi M, Sommer IEC, Stahl SM, Pignon B, Berna F. Fond G, et al. Among authors: misdrahi d. BMJ Ment Health. 2023 Oct;26(1):e300771. doi: 10.1136/bmjment-2023-300771. BMJ Ment Health. 2023. PMID: 37852631 Free PMC article.
Development of the PREMIUM computerized adaptive testing for measuring the access and care coordination for patients with severe mental illness.
Boyer L, Fernandes S, Brousse Y, Zendjidjian X, Cano D, Riedberger J, Llorca PM, Samalin L, Dassa D, Trichard C, Laprevote V, Sauvaget A, Abbar M, Misdrahi D, Berna F, Lancon C, Coulon N, El-Hage W, Rozier PE, Benoit M, Giordana B, Caqueo-Urizar A, Yon DK, Tran B, Auquier P, Fond G. Boyer L, et al. Among authors: misdrahi d. Psychiatry Res. 2023 Oct;328:115444. doi: 10.1016/j.psychres.2023.115444. Epub 2023 Sep 1. Psychiatry Res. 2023. PMID: 37677894
Clinical and pharmacological correlates of caffeine consumption in subjects with schizophrenia - Data from the FACE-SZ cohort.
Szoke A, Richard JR, Fond G, Misdrahi D, Lajnef M, Aouizerate B, Boyer L, Berna F, Capdevielle D, André M, Chereau I, Clauss-Kobayashi J, Coulon N, Dubertret C, Leignier S, Llorca PM, Mallet J, Passerieux C, Rey R, Schorr B, Urbach M, Leboyer M, Pignon B, Schürhoff F; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group. Szoke A, et al. Among authors: misdrahi d. J Psychiatr Res. 2023 May;161:206-212. doi: 10.1016/j.jpsychires.2023.03.017. Epub 2023 Mar 13. J Psychiatr Res. 2023. PMID: 36934602
Mood Variability, Craving, and Substance Use Disorders: From Intrinsic Brain Network Connectivity to Daily Life Experience.
Morawetz C, Berboth S, Chirokoff V, Chanraud S, Misdrahi D, Serre F, Auriacombe M, Fatseas M, Swendsen J. Morawetz C, et al. Among authors: misdrahi d. Biol Psychiatry Cogn Neurosci Neuroimaging. 2023 Sep;8(9):940-955. doi: 10.1016/j.bpsc.2022.11.002. Epub 2022 Nov 10. Biol Psychiatry Cogn Neurosci Neuroimaging. 2023. PMID: 36775712 Free article.
Relationships between neuropsychological performance, insight, medication adherence, and social metacognition in schizophrenia.
Roux P, Faivre N, Urbach M, Aouizerate B, Brunel L, Capdevielle D, Chereau I, Dubertret C, Dubreucq J, Fond G, Lançon C, Leignier S, Mallet J, Misdrahi D, Pires S, Schneider P, Schurhoff F, Yazbek H, Zinetti-Bertschy A, Passerieux C, Brunet-Gouet E. Roux P, et al. Among authors: misdrahi d. Schizophr Res. 2023 Feb;252:48-55. doi: 10.1016/j.schres.2022.12.037. Epub 2023 Jan 7. Schizophr Res. 2023. PMID: 36623435
59 results